1. |
王颢, 傅传刚. 直肠癌术前准确分期价值及对治疗策略选择的影响. 中国实用外科杂志, 2014, 34(1): 37-40.
|
2. |
中国抗癌协会结直肠癌专业委员会. 中国结直肠癌诊疗规范(2025年版). 中华肿瘤杂志, 2025, 47(3): 201-215.
|
3. |
汪晓东, 刘健博, 李立. 数据库建设第五部分·结直肠癌的肿瘤特征—模块的设计(二). 中国普外基础与临床杂志, 2020, 27(4): 483-488.
|
4. |
汪晓东, 刘健博, 李立. 数据库建设第五部分: 结直肠癌的肿瘤特征—模块的设计(一). 中国普外基础与临床杂志, 2020, 27(3): 345-349.
|
5. |
汪晓东, 李立. 数据库建设第一部分: 个人数据的标签与结构化. 中国普外基础与临床杂志, 2019, 26(3): 335-342.
|
6. |
朱利微, 徐淑云, 辛海龙, 等. NRS2002营养风险筛查的临床应用及研究. 当代医学, 2011, 17(8): 30.
|
7. |
汪晓东, 刘健博, 李立. 数据库建设第三部分: 结直肠癌内外科合并症及术前体质状态的标签与结构化. 中国普外基础与临床杂志, 2019, 26(9): 1110-1115.
|
8. |
中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版). 中华外科杂志, 2020, 58(8): 561-585.
|
9. |
国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组. 中国结直肠癌筛查与早诊早治指南(2020, 北京). 中国肿瘤, 2021, 30(1): 1-28.
|
10. |
汪晓东, 林容若, 刘健博, 等. 数据库建设第七部分: 结直肠癌手术特征的标签与结构化(一). 中国普外基础与临床杂志, 2020, 27(9): 1150-1152.
|
11. |
Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: Rectal cancer, version 6. 2020. J Natl Compr Canc Netw, 2020, 18(7): 806-815.
|
12. |
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2017, 28(suppl_4): iv22-iv40. doi: 10.1093/annonc/mdx224.
|
13. |
Nagtegaal ID, Tot T, Jayne DG, et al. Lymph nodes, tumor deposits, and TNM: are we getting better?. J Clin Oncol, 2011, 29(18): 2487-2492.
|
14. |
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004, 351(17): 1731-1740.
|
15. |
van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet, 2018, 391(10139): 2537-2545.
|
16. |
Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet, 2009, 373(9666): 821-828.
|
17. |
Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery—The clue to pelvic recurrence?. Br J Surg, 1982, 69(10): 613-616.
|
18. |
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 2001, 345(9): 638-646.
|
19. |
Weimann A, Braga M, Carli F, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr, 2017, 36(3): 623-650.
|
20. |
Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr, 2017, 36(1): 11-48.
|
21. |
Garcia-Aguilar J. Chemoradiotherapy and local excision for organ preservation in early rectal cancer—The end of the beginning?. JAMA Surg, 2019, 154(1): 54-55.
|